High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

Human Reproduction

Volumn 14, Issue 11, 1999, Pages 2700-2703

  Mitwally, M F M ^a   Kuscu, N K ^a   Yalcinkaya, T M ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Clomiphene resistant; Ovulatory rate; Polycystic ovary syndrome; Troglitazone

Indexed keywords

CLOMIFENE; METFORMIN; TROGLITAZONE;

ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; FEMALE INFERTILITY; HUMAN; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE;

FALLOPIA;

EID: 0032708106     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.11.2700     Document Type: Article

References (23)

1. Berga, S.L, and Yen, S.S. (1989) Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 30, 177-184.
2. Burghen, G.A., Givens, J.R. and Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 50, 113-116.
3. Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1983) Insulin resistance in non-obese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356-359.
4. Dor, J., Itzkowic, D.J., Mashiach, S. et al. (1980) Cumulative conception rates following gonadotropin therapy. Am. J. Obstet. Gynecol., 136, 102-105.
5. Dunaif, A., Sorbara, L. and Delson, R. et al. (1993) Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes, 42, 1462-1468.
6. Dunaif, A., Scott, D., Finegood, D. et al. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 3299-3306.
7. Ehrmann, D.A., Cavaghan, M.K., Imperial, J. et al (1997a) Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome. J. Clin. Endocrinol Metab., 82, 524-530.
8. Ehrmann, D.A., Schneider, D.J., Sobel, B.E. et al. (1997b) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 2108-2116.
9. Espinosa de los Monteros, A., Ayala, J., Sanabria, L.C. et al. (1995) Serum insulin in clomiphene responders and non-responders with polycystic ovarian disease. Rev. Invest. Clin., 47, 347-353.
10. Fluker, M.R., Urman, B., Mackinnon, M. et al. (1994) Exogenous gonadotropin therapy in World Health Organization Groups I and II ovulatory disorders. Obstet. Gynecol., 83, 189-196.
11. Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853-861 [Erratum, N. Engl. J. Med., (1995), 333, 1435].
12. Holte, J., Bergh, T., Berne, C. et al. (1994) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab., 78, 1052-1058.
13. Homburg, R., Weissglas, L. and Goldman, J. (1988) Improved treatment for anovulation in polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotrophin release and clomiphene response. Hum. Reprod., 3, 285-288.
14. Lobo, R.A., Gysler, M., March C.M. et al. (1982) Clinical and laboratory predictors of clomiphene response. Fertil. Steril., 37, 168-174.
15. March, C.M. (1987) Improved pregnancy rate with monitoring of gonadotropin therapy by three modalities. Am. J. Obstet. Gynecol., 156, 1473-1479.
16. Nestler, J.E., Jakubowicz, D.J., Evans, W.S. et al. (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med., 338, 1876-1880.
17. NIDDK News Briefs (1998) National Institute of Diabetes and Digestive and Kidney Diseases Web site. Available at http://www. niddk. nih. gov/new/ newsbref/troglita. htm, accessed June 4, 1998.
18. Norman, S., Mahabeer, S. and Masters, S. (1995) Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil. Steril., 63, 58-62.
19. Rezulin [package insert] (1998) Park-Davis, Morris Plains, NJ.
20. Shepard, M.K., Balmaceda, J.P. and Leija, C.G. (1979) Relationship of weight to successful induction of ovulation with clomiphene citrate. Fertil. Steril., 32, 641-645.
21. Shoham, Z. and Weissman, A. (1998) Polycystic ovarian disease: obesity and insulin resistance. Proc. IFFS, 263-272.
22. van Montraus, J.M., van Hooff, M.H.A., Hompes, P.G.A. and Lambalk, C.B. (1998) Treatment of hyperinsulinaemia in polycystic ovary syndrome. Hum. Reprod., 13, 5-6.
23. Zawadzki, J.K. and Dunaif, A. (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif, A., Givens, J.R., Haseltine, F. and Merriam, G.R. (eds), Polycystic Ovary Syndrome. Blackwell, Boston, pp. 377-384.